45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,722
Insurances with rates
6
CPT / HCPCS codes
1,783
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION | $240,050 | $120,025 | — | — | 0 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $135,077 | $67,538 | — | — | 1 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $111,116 | $55,558 | — | — | 1 |
| J9118 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $100,183 | $50,091 | — | — | 0 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $91,682 | $45,841 | — | — | 1 |
| J9281 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT | $88,490 | $44,245 | — | — | 6 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $81,970 | $40,985 | — | — | 0 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $74,496 | $37,248 | — | — | 1 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $74,456 | $37,228 | — | — | 0 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $60,528 | $30,264 | — | — | 1 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $58,741 | $29,371 | — | — | 5 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $57,485 | $28,742 | — | — | 2 |
| J9316 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $55,716 | $27,858 | — | — | 1 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $48,850 | $24,425 | — | — | 0 |
| C9399 | ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION | $47,550 | $23,775 | — | — | 4 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $47,228 | $23,614 | — | — | 1 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $45,057 | $22,529 | — | — | 3 |
| J9153 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $43,120 | $21,560 | — | — | 6 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $42,477 | $21,239 | — | — | 1 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $42,126 | $21,063 | — | — | 2 |
| J9203 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $40,230 | $20,115 | — | — | 1 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $35,559 | $17,779 | — | — | 1 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $34,501 | $17,250 | — | — | 1 |
| J9223 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $32,490 | $16,245 | — | — | 0 |
| J1323 | ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION | $30,273 | $15,136 | — | — | 6 |
| J9273 | TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION | $28,542 | $14,271 | — | — | 0 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $27,332 | $13,666 | — | — | 1 |
| J9311 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $26,356 | $13,178 | — | — | 0 |
| J1299 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $26,142 | $13,071 | — | — | 2 |
| C1604 | SYSTEM CAP FOR ANY NUMBER OF TORUS STENT GRAFTS AND ENDOCROSS DEVICE DETOUR | $25,000 | $12,500 | — | — | 0 |
| J2860 | SILTUXIMAB 400 MG INTRAVENOUS SOLUTION | $24,721 | $12,361 | — | — | 1 |
| J9207 | IXABEPILONE 45 MG INTRAVENOUS SOLUTION | $24,225 | $12,112 | — | — | 2 |
| J0717 | CERTOLIZUMAB PEGOL 400 MG (200 MG X 2 VIALS) SUBCUTANEOUS KIT | $24,048 | $12,024 | — | — | 1 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $23,178 | $11,589 | — | — | 4 |
| J9039 | BLINATUMOMAB 35 MCG INTRAVENOUS KIT | $22,275 | $11,137 | — | — | 0 |
| C1722 | DEFIBRILLATOR EMBLEM S-ICD 130 GM D12.7 MM W83.1 MM X H69.1 MM CARDIAC | $21,500 | $10,750 | — | — | 3 |
| J9021 | ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION | $20,983 | $10,492 | — | — | 2 |
| J9015 | ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLUTION | $20,588 | $10,294 | — | — | 0 |
| J9057 | COPANLISIB 60 MG INTRAVENOUS SOLUTION | $20,248 | $10,124 | — | — | 2 |
| C1767 | GENERATOR NEUROSTIMULATOR L5.02 CM X H6.68 CM THK1.35 CM 25.5-MA 2-1200HZ 38.6 CU CM 7 IMPLANTABLE P | $19,500 | $9,750 | — | — | 3 |
| J9356 | TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION | $18,751 | $9,376 | — | — | 3 |
| C1817 | OCCLUDER AMPLATZER AMULET 16MM 22MM NITINOL PLASTIC 7.5X11-13MM 10- MM CARDIOVASCULAR HEMOSTASIS VAL | $18,000 | $9,000 | — | — | 3 |
| J9177 | ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION | $16,904 | $8,452 | — | — | 4 |
| J9173 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $16,892 | $8,446 | — | — | 2 |
| C1820 | GENERATOR NEUROSTIMULATOR 16 CONTACT PRECISION MONTAGE MRI | $16,500 | $8,250 | — | — | 2 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $16,009 | $8,004 | — | — | 4 |
| J9299 | NIVOLUMAB 120 MG/12 ML INTRAVENOUS SOLUTION | $15,625 | $7,812 | — | — | 3 |
| J9061 | AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION | $15,277 | $7,638 | — | — | 0 |
| L8670 | GRAFT STENT 25MM 13MM 80MM 40MM 2 BRANCH AAA AFX2 MAIN BODY ILIAC LIMB STERILE LATEX FREE | $14,999 | $7,500 | — | — | 4 |
| L8670 | GRAFT STENT 22MM 16MM 70MM 30MM 2 BRANCH AAA AFX2 MAIN BODY ILIAC LIMB STERILE LATEX FREE | $14,999 | $7,500 | — | — | 1 |
Showing top 50 of 2,722 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.